Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students.
Psychotropic drug treatment in learning-disabled (LD), educable mentally retarded (EMR), and seriously emotionally disturbed (ED) children and adolescents receiving public school special education services was examined. The findings indicated that while treatment prevalence rates for EMR and ED groups were comparable, the rate for LD students was much lower. In the LD sample, pharmacotherapy was associated with higher ratings of behavioral deviance, longer placement in special education, less social integration, and greater peer rejection, which suggests that symptom severity is an important determiner of pharmacotherapy in this population.
Cullinan
D
D
Department of Curriculum and Instruction, North Carolina State University, Raleigh 27695-7801.
Gadow
K D
KD
Epstein
M H
MH
D000124:Achievement; D000293:Adolescent; D000342:Affective Symptoms / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D004495:Education of Persons with Intellectual Disabilities; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy* / Q000523:psychology; D007859:Learning Disabilities / Q000188:drug therapy* / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012917:Social Adjustment
D011619:Psychotropic Drugs